Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 161 member A (FAM161A) is a ciliary–centrosomal protein predominantly expressed in retinal photoreceptors, localizing to the connecting cilium, basal body, and centrioles[2][3][6]. FAM161A regulates microtubule stability and acetylation, playing a critical structural role in maintaining photoreceptor architecture and facilitating protein transport between inner and outer segments[2][3][5]. Mutations in FAM161A disrupt ciliary integrity, impair protein trafficking, and are a causative factor for autosomal recessive retinitis pigmentosa type 28 (RP28), a progressive retinal degenerative disease marked by early photoreceptor dysfunction and vision loss[1][4][5]. While not considered a classical drug target (e.g., receptor, enzyme), FAM161A is the subject of gene therapy research aimed at restoring its function in retinal disease[5]. Precise gene regulation is necessary in therapeutic strategies, as both deficiency and overexpression are tied to disease phenotypes and safety considerations[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 161 member A (FAM161A).